2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1598007676 MD
Verify on CMS →

AVNI SHAH, MD

Glaucoma Specialist (Ophthalmology) Physician in SANTA ROSA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 625 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.7144/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$134.22
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AVNI SHAH, MD reported a CMS MIPS final score of 94.7144/100 — above the 83.1 national average — and filed 2,444 Medicare Part D claims in 2023.

94.7144/100
MIPS score · +12 vs avg
2K
Part D claims, 2023
53%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AVNI SHAH, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

AVNI SHAH, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AVNI SHAH, MD?

High performer (top quartile)

NPI registry status

Active

Issued 03/26/2013

NPI 1598007676

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

2,444 17% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

94.7144/100 11.614400000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Glaucoma Specialist (Ophthalmology) Physician share within California

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

AVNI SHAH, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
94.7144/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 94.7144/100 vs national avg 83.1

0%100%National avg83%94.7%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 94.7144/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AVNI SHAH, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in SANTA ROSA, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1598007676. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AVNI SHAH, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 3035 CLEVELAND AVE STE 100, SANTA ROSA, CA, 95403, with a listed phone of (708) 623-8200. NPI 1598007676 was issued on 03/26/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHAH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,444 prescription claims written by this provider, covering 625 Medicare beneficiaries and totaling roughly $377K in drug spend, split 47% brand-name and 53% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.7144/100 for the 2023 performance year (Quality 100, Cost 82.3813), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3035 CLEVELAND AVE STE 100
SANTA ROSA, CA 95403

Provider Details

NPI 1598007676
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 03/26/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.7144
Final Score
Avg: 83.1
100
Quality
82.3813
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where AVNI SHAH, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE CARE INSTITUTE A MEDICAL CORPORATION
SANTA ROSA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AVNI SHAH, MD. Source: openpaymentsdata.cms.gov.

Total received

$134

Largest payer

Rayner Intraocular Lenses Limited

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to AVNI SHAH, MD. To verify AVNI SHAH, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

AVNI SHAH, MD — brand share 47.0%
Specialty average (est.)

47% brand-name claims vs 53% generic, on 2,444 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,444
Total Claims
$377K
Total Drug Cost
625
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,324
Total Day Supply
156,496
Brand vs Generic
47% brand / 53% generic
Brand Drug Cost
$314K
Generic Drug Cost
$63K
Antibiotic Claims
33

Patient Demographics

Average Patient Age
76.4 years
Avg HCC Risk Score
1.11
Gender Split
57% female / 43% male
Age Distribution
<65: 21, 65-74: 253, 75-84: 254, 85+: 97

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
756
Prednisolone Acetate
272
Timolol Maleate
254
Brimonidine Tartrate
174
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
160
Lumigan
Bimatoprost
106
Rhopressa
Netarsudil Mesylate
81
Rocklatan
Netarsudil Mesylat/Latanoprost
80
Diclofenac Sodium
63
Dorzolamide Hcl
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How AVNI SHAH, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

AVNI SHAH, MD's 2,444 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SHAH.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AVNI SHAH, MD's specialty?
AVNI SHAH, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in SANTA ROSA, California. Credentials: MD.
How much does AVNI SHAH, MD prescribe under Medicare Part D?
In 2023, AVNI SHAH, MD wrote 2,444 Medicare Part D claims totaling $377K in drug costs for 625 beneficiaries.
What is AVNI SHAH, MD's Medicare quality score?
AVNI SHAH, MD has a CMS MIPS Final Score of 94.7144/100 (Quality: 100, Cost: 82.3813). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AVNI SHAH, MD located?
AVNI SHAH, MD is located at 3035 CLEVELAND AVE STE 100, SANTA ROSA, CA, 95403. Phone: (708) 623-8200.
What is AVNI SHAH, MD's NPI number?
AVNI SHAH, MD's National Provider Identifier (NPI) is 1598007676, issued on 03/26/2013.
Does AVNI SHAH, MD prescribe more brand-name or generic drugs?
AVNI SHAH, MD's prescribing is 47% brand-name and 53% generic drugs by claim count, with $314K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does AVNI SHAH, MD prescribe most often?
Based on 2023 Medicare Part D data, AVNI SHAH, MD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AVNI SHAH, MD accept Medicare?
AVNI SHAH, MD appears in CMS Medicare data with 2,444 Part D claims and 625 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AVNI SHAH, MD's credentials?
AVNI SHAH, MD's NPI is 1598007676 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology